BioCentury
ARTICLE | Financial News

Novo's REPAIR fund investments total €18M in 2018

January 25, 2019 5:09 PM UTC

Novo Holdings A/S (Hellerup, Denmark) said its REPAIR Impact Fund invested in antibacterial companies Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), MinervaX ApS (Copenhagen, Denmark) and Procarta Biosystems Ltd. (Norwich, U.K.), bringing the fund's 2018 total investment to €18 million.

The fund invested $10 million in Entasis' $75 million September 2018 IPO, €3.6 million in MinervaX and €1.5 million in Procarta...